Frailty Assessment: Matching Simplification Efforts to Clinical Aims

衰弱评估:将简化工作与临床目标相匹配

基本信息

  • 批准号:
    8772844
  • 负责人:
  • 金额:
    $ 8.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-15 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Frailty has been theoretically defined as a clinically recognizable state of increased vulnerability in older adults. Although numerous instruments have been developed to identify frailty, consensus on best measures has not been achieved. The two most commonly cited frailty measures in the geriatric literature are the Physical Frailty Phenotype (PFP) and the Frailty Index (FI). The number of citations of the FI and the PFP has quintupled and octupled respectively in last five years. With the growing popularity of these instruments simplifications and approximations of existing phenotypes have proliferated, typically motivated by either availability of measures in specific studies or the demand for speed and ease of patient evaluation in clinical practice. The idea of tailoring measures to specific research or clinical settings may be appealing. However, there also are potential harms if the instruments measure fundamentally different aspects of older adults' health, or if they are differentially effective in accomplishing different aims of frailty ascertainment (e.g., frailty syndrome characterization vs. risk stratification). Although a number of epidemiological studies have been conducted to compare the different frailty assessment tools, the comparisons so far have almost exclusively focused on predictive validity. Using data collected over 9 years in the 5888 older adults age 65 and older from the Cardiovascular Health Study, this study conducts the comparative analysis in a novel direction to: systematically evaluate possible simplifications of the PFP criteria that could be used for (1) their internal validity regarding frailty syndrome identification, (2) accuracy in discriminating the risk of frail and non-frail persons for adverse outcomes of aging, (3) usefulness as a potential marker of increased vulnerability, as well as (4) determine the level, sources, and predictors of the discordance between the PF and the FI in frailty classification. By elucidating the values and limits of the two most commonly used frailty instruments and assessing potential simplifications of the PFP, the proposed study promises to provide much needed guidance on the selection of frailty measures to match clinical aims of frailty assessment, with the ultimate goal of identifying new arenas for frailty prevention and treatment.
描述(由申请人提供): 虚弱在理论上被定义为老年人中临床上可识别的脆弱性增加的状态。虽然已经制定了许多工具来确定脆弱性,但尚未就最佳措施达成共识。老年医学文献中最常引用的两种虚弱指标是身体虚弱表型(PFP)和虚弱指数(FI)。在过去五年中,引用第四国际和私营部门筹资伙伴关系的次数分别增加了五倍和八倍。随着这些工具的日益普及,现有表型的简化和近似已经激增,通常由特定研究中的测量的可用性或临床实践中对患者评估的速度和容易性的需求所驱动。根据具体的研究或临床环境定制措施的想法可能很有吸引力。然而,如果这些仪器测量老年人健康的根本不同方面,或者如果它们在实现虚弱确定的不同目标方面有差异,也会有潜在的危害(例如,虚弱综合征表征与风险分层)。虽然已经进行了一些流行病学研究来比较不同的虚弱评估工具,但迄今为止的比较几乎完全集中在预测有效性上。使用心血管健康研究中5888名65岁及以上老年人9年来收集的数据,本研究在一个新的方向进行了比较分析:系统地评价PFP标准的可能简化,其可用于(1)关于虚弱综合征识别的内部有效性,(2)区分体弱和非体弱者对老龄化不良后果的风险的准确性,(3)作为脆弱性增加的潜在标志的有用性,以及(4)确定水平,来源,以及PF和FI在虚弱分类中的不一致性的预测因子。通过阐明两种最常用的虚弱工具的价值和限制,并评估PFP的潜在简化,拟议的研究有望为虚弱评估的临床目标提供选择虚弱措施的指导,最终目标是确定新的虚弱预防和治疗领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Qian-Li Xue其他文献

Qian-Li Xue的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Qian-Li Xue', 18)}}的其他基金

The Johns Hopkins Alzheimer's Disease Resource Center for Minority Aging Research - Analysis Core
约翰霍普金斯大学阿尔茨海默氏病资源中心少数民族老龄化研究 - 分析核心
  • 批准号:
    10451583
  • 财政年份:
    2018
  • 资助金额:
    $ 8.1万
  • 项目类别:
Physical Frailty and Cognitive Impairment: Intersection, Measurement & Etiologies
身体虚弱和认知障碍:交叉点、测量
  • 批准号:
    9336220
  • 财政年份:
    2016
  • 资助金额:
    $ 8.1万
  • 项目类别:
Clinical Significance of Short-term Change and Variability of Grip Strength
握力短期变化和变异的临床意义
  • 批准号:
    8451339
  • 财政年份:
    2012
  • 资助金额:
    $ 8.1万
  • 项目类别:
Clinical Significance of Short-term Change and Variability of Grip Strength
握力短期变化和变异的临床意义
  • 批准号:
    8283048
  • 财政年份:
    2012
  • 资助金额:
    $ 8.1万
  • 项目类别:
Biostatistics Core - RC1
生物统计学核心 - RC1
  • 批准号:
    10728746
  • 财政年份:
    2003
  • 资助金额:
    $ 8.1万
  • 项目类别:
The Johns Hopkins Alzheimer's Disease Resource Center for Minority Aging Research - Analysis Core
约翰霍普金斯大学阿尔茨海默氏病资源中心少数民族老龄化研究 - 分析核心
  • 批准号:
    9770746
  • 财政年份:
  • 资助金额:
    $ 8.1万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 8.1万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了